BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma
Authors
Keywords
Peritoneal mesothelioma, BAP1, Genomics, Tumor immunosurveillance, Precision oncology
Journal
Genome Medicine
Volume 11, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-02-18
DOI
10.1186/s13073-019-0620-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CONFIRM: a double-blind, placebo-controlled phase III clinical trial investigating the effect of nivolumab in patients with relapsed mesothelioma: study protocol for a randomised controlled trial
- (2018) Dean A. Fennell et al. Trials
- Integrative Molecular Characterization of Malignant Pleural Mesothelioma
- (2018) Julija Hmeljak et al. Cancer Discovery
- HIT'nDRIVE: patient-specific multidriver gene prioritization for precision oncology
- (2017) Raunak Shrestha et al. GENOME RESEARCH
- The Immune Microenvironment, Genome-wide Copy Number Aberrations, and Survival in Mesothelioma
- (2017) Bibhusal Thapa et al. Journal of Thoracic Oncology
- BAP1 Is Altered by Copy Number Loss, Mutation, and/or Loss of Protein Expression in More Than 70% of Malignant Peritoneal Mesotheliomas
- (2017) Noémie Leblay et al. Journal of Thoracic Oncology
- Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial
- (2017) Michele Maio et al. LANCET ONCOLOGY
- Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial
- (2017) Evan W Alley et al. LANCET ONCOLOGY
- BAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformation
- (2017) Angela Bononi et al. NATURE
- DNA Damage and Repair Biomarkers of Immunotherapy Response
- (2017) Kent W. Mouw et al. Cancer Discovery
- Association of Asbestos Exposure With Malignant Mesothelioma Incidence in Eastern China
- (2017) Weimin Mao et al. JAMA Oncology
- Genomic copy number alterations in 33 malignant peritoneal mesothelioma analyzed by comparative genomic hybridization array
- (2016) Pierre Chirac et al. HUMAN PATHOLOGY
- Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2 and DDX3X
- (2016) Nancy M Joseph et al. MODERN PATHOLOGY
- Genomic Landscape of Malignant Mesotheliomas
- (2016) S. Kato et al. MOLECULAR CANCER THERAPEUTICS
- Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations
- (2016) Raphael Bueno et al. NATURE GENETICS
- High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma
- (2016) Yoshie Yoshikawa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Quantitative Profiling of Single Formalin Fixed Tumour Sections: proteomics for translational research
- (2016) Christopher S. Hughes et al. Scientific Reports
- High Incidence of Somatic BAP1 Alterations in Sporadic Malignant Mesothelioma
- (2015) Masaki Nasu et al. Journal of Thoracic Oncology
- BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma
- (2015) Hakan Alakus et al. Journal of Translational Medicine
- The prognostic significance of BAP1, NF2 and CDKN2A in malignant peritoneal mesothelioma
- (2015) Aatur D Singhi et al. MODERN PATHOLOGY
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- Efficacy and safety of an intensified schedule of tremelimumab for chemotherapy-resistant malignant mesothelioma: an open-label, single-arm, phase 2 study
- (2015) Luana Calabrò et al. Lancet Respiratory Medicine
- Personalized Oncogenomics: Clinical Experience with Malignant Peritoneal Mesothelioma Using Whole Genome Sequencing
- (2015) Brandon S. Sheffield et al. PLoS One
- HTSeq--a Python framework to work with high-throughput sequencing data
- (2014) S. Anders et al. BIOINFORMATICS
- Whole-Exome Sequencing Reveals Frequent Genetic Alterations in BAP1, NF2, CDKN2A, and CUL1 in Malignant Pleural Mesothelioma
- (2014) G. Guo et al. CANCER RESEARCH
- Germline Mutations in BAP1 Impair Its Function in DNA Double-Strand Break Repair
- (2014) I. H. Ismail et al. CANCER RESEARCH
- Ultrasensitive proteome analysis using paramagnetic bead technology
- (2014) C. S. Hughes et al. Molecular Systems Biology
- STRING v10: protein–protein interaction networks, integrated over the tree of life
- (2014) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial
- (2013) Luana Calabrò et al. LANCET ONCOLOGY
- Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair
- (2013) H. Yu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inferring tumour purity and stromal and immune cell admixture from expression data
- (2013) Kosuke Yoshihara et al. Nature Communications
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration
- (2012) H. Thorvaldsdottir et al. BRIEFINGS IN BIOINFORMATICS
- The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma
- (2011) Matthew Bott et al. NATURE GENETICS
- A framework for variation discovery and genotyping using next-generation DNA sequencing data
- (2011) Mark A DePristo et al. NATURE GENETICS
- GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
- (2011) Craig H Mermel et al. GENOME BIOLOGY
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
- (2010) K. Wang et al. NUCLEIC ACIDS RESEARCH
- Differential expression analysis for sequence count data
- (2010) Simon Anders et al. GENOME BIOLOGY
- Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973–2005
- (2009) Suresh H. Moolgavkar et al. CANCER CAUSES & CONTROL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started